Markers of connective tissue activation in aseptic hip prosthetic loosening

Journal of Arthroplasty

Volumn 12, Issue 6, 1997, Pages 695-703

  Moreschini, O ^a   Fiorito, S ^b,d   Magrini, L ^c   Margheritini, F ^a   Romanini, L ^a  

^a Orthopaedic Department   (Italy)

^b Department of Experimental Medicine ^*  (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NONE   (Italy)

Author keywords

Aseptic hip prosthesis loosening; Fibroblasts; Macrophages; Markers

Indexed keywords

CELL MARKER; HYALURONIC ACID; INTERLEUKIN 1BETA; PROCOLLAGEN;

ARTICLE; ASEPTIC NECROSIS; CONNECTIVE TISSUE; HIP PROSTHESIS; MACROPHAGE ACTIVATION; PROSTHESIS LOOSENING;

EID: 0030876226     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-5403(97)90144-3     Document Type: Article

References (31)

1. Santavirta S, Konttinen YT, Hikka V, Eskola A: Immunopathological response to loose cementless acetabular components. J Bone Joint Surg 73B:38, 1991
2. Santavirta S, Pajamaki J, Eskola A et al: Proliferative cell response to loosening of total hip replacements: a cytofluorographic cell cycle analysis. Arch Orthop Trauma Surg 111:43, 1991
3. Goldring SR, Schiller AL, Roelke M et al. The synovial-like membrane at the bone-cement interface in loose total hip replacement and its proposed role in bone lysis. J Bone Joint Surg 65A:575, 1983
4. Kim KJ, Rubash HE, Wilson SC et al: A histological and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287:142, 1993
5. Chiba J, Rubash HE, Kang Jung K, Iwaki Y: The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop 300:304, 1994
6. Horowitz SM, Rapuano BP, Lane JM, Burstein AH: The interaction of the macrophages and the osteoblast in the pathophysiology of aseptic loosening of joint replacements. Calcif Tissue Int 54:320, 1994
7. Jiranek WA, Machado MBS, Jasty M et al: Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75A:8 63, 1993
8. Westecott CI, Taylor GT, Atkins R, Elson C: Interleukin 1-alpha and 1-beta production by cells isolated from membranes around aseptically loose total joint replacements. Ann Rheum Dis 51:638, 1992
9. Diegelman RF, Cohen IK, Kaplan AM: The role of macrophages in wound repair. Plast Reconstr Surg 68:107, 1981
10. Aalto M, Potila M, Kulonene E: The effects of silica-treated macrophages on the synthesis of collagen and other proteins in vitro. Exp Cell Res 97:193, 1976
11. Casey WJ, Peacock EE Jr, Chvapil M: Induction of collagen synthesis in rats by transplantation of allogenic macrophages. Surg Forum 27: 53, 1976
12. Pulkki K, Vuorio E, Jalava S: The effects of rheumatoid synovial fluid macrophages on DNA, glycosaminoglycan and collagen synthesis by synovial fibroblasts. Rheumatol Int 3:133, 1983
13. Bjermer L, Engstrom-Laurent A, Lundgren R et al: Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br Med J 295:803, 1987
14. Bjork J, Kleinau S, Tengblad A, Smedegard G: Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis. Arthritis Rheum 32:306, 1989
15. Engstrom-Laurent A, Feltelius N, Hallgren R, Wasteson A: Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells. Ann Rheum Dis 44:614, 1985
16. Engstrom-Laurent A, Hallgren R: Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83, 1985
17. Engstrom-Laurent A, Hallgren R: Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Arthritis Rheum 30:1333, 1987
18. Petersen HK, Bentsen KD, Junker P, Lorenzen IB: Serum aminoterminal type III procollagen peptide in rheumatoid arthritis. Arthritis Rheum 29:592, 1986
19. Bennett NE, Wang JT, Manning CA, Goldring SR: Activation of human monocyte/macrophages and fibroblasts by metal particles, release of products with bone resorbing activities. Trans Orthop Res Soc 16:188, 1991
20. Moreschini O, Margheritini F: A histological evaluation of the bone-implant interface failure in total hip arthroplasty due to aseptic loosening. Hip Int 3(2):46, 1993
21. Monticelli G, Romanini L, Moreschini O: A review on the aseptic total hip replacement failures. p. 35. In Ravaglioli A, Krajewsky A (eds): Bioceramic and human body. Faenza, Italy, 1993
22. Konttinen YT, Kurvinen H, Takagi M et al: Interleukin-1 and collagenases around loosening total hip prostheses. Clin Exp Rheumatol 14:255, 1996
23. Di Giovine FS, Malawista SE, Nuki G, Duff GW: Interleukin 1 as mediator of crystal arthritis: stimulation of T cell and synovial fibroblast mitogenesis by urate-induced IL-1. J Immunol 138:3213, 1987
24. Dahl LB, Dahl IMS, Engstrom-Laurent A, Granath K: Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817, 1985
25. Vuorio E, Einola S, Hakkarmen S, Penttinen R: Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and nonrheumatoid synovitis. Rheumatol Int 2:97, 1982
26. 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint disease. Clin Chim Acta 141:241, 1984
27. Eastgate JA, Symons JA, Wood NC et al: Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet, 706, 1988
28. Bhardway N, Laul L, Rivelis M, Steinman RM: Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Cell Immunol 114:405, 1988
29. Hammermann D, Wood DD: Interleukin-1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 177:205, 1984
30. Athanasou NA, Quinn J, Bulstrode CJK: Resorption of bone by inflammatory cells derived from the joint capsule of hip arthroplasties. J Bone Joint Surg 74B:57, 1992
31. Haynes DR, Rogers SD, Hay S et al: The differences in toxicity and release of bone resorbing mediators induced by titanium and cobalt-chromium alloy wear particles. J Bone Joint Surg 75A:825, 1993